Bio-Rad Laboratories | BIO - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
Abbott USD 2.25B 73M 2025-12
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
General Electric Aerospace USD 1.77B 536M 2025-12
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Merck USD 6.24B 318M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Siemens EUR 2.57B 3M 2025-12
Standard Biotools USD -21.92M 1.55M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Tosoh JPY 25.15B 3.51B 2025-12
Waters USD 270.52M 78.4M 2025-12